Ardent Health Partners, Inc. (ARDT) Stock Forecast
ARDT analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.92 / 5 from 13 analysts
- Price target
- $12.67 average of analyst targets
- Upside to target
- +6.0% from the latest close
- Next earnings
- November 11, 2026 EPS estimate $0.24
- 52-week range
- $7.83 – $15.21
ARDT analyst ratings
13 analystsNumber of analysts at each rating.
ARDT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ARDT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.24 | $0.13 | $0.34 | $0.83 | −70.5% | 4 |
| Current fiscal year (2026) | $1.09 | $0.81 | $1.56 | $1.54 | −29.6% | 4 |
| Next fiscal year (2027) | $1.25 | $1.09 | $1.49 | $1.09 | +15.4% | 4 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ARDT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.60B | $1.57B | $1.63B | +1.7% | 11 |
| Current fiscal year (2026) | $6.46B | $6.40B | $6.51B | +2.2% | 12 |
| Next fiscal year (2027) | $6.73B | $6.56B | $6.83B | +4.1% | 12 |
ARDT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ARDT revenue: reported and forecast
ARDT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.25 | $0.25 | $0.24 | $0.24 | $0.24 | −3.0% | 1 up · 2 down |
| Current fiscal year (2026) | $1.29 | $1.09 | $1.09 | $1.09 | $1.09 | −15.7% | 0 up · 2 down |
| Next fiscal year (2027) | $1.25 | $1.23 | $1.25 | $1.25 | $1.25 | +0.8% | 0 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ARDT earnings surprises
Reported EPS vs the consensus estimate for the last 10 quarters; ARDT beat in 7 of 10.
What analysts expect from ARDT
13 analysts cover Ardent Health Partners; their consensus rating is buy (3.92 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.67, 6.0% above the latest close of $11.95. Analysts expect earnings of $1.09 per share for 2026, −29.6% from a year earlier. For 2027 the average estimate is $1.25 per share on revenue of $6.7 billion. Ardent Health Partners beat the EPS estimate in 7 of the last 10 quarters.
Related: ARDT income statement, ARDT key metrics, ARDT chart. See the ARDT stock overview for the latest quote and news.
ARDT forecast FAQ
What is Ardent Health Partners's price target?
The average analyst price target for Ardent Health Partners is $12.67, 6.0% above the latest close of $11.95.
Is Ardent Health Partners a buy, hold or sell?
Of 13 analysts covering Ardent Health Partners, 6 rate it a strong buy, 1 a buy, 5 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Ardent Health Partners's EPS forecast?
Analysts forecast $1.09 per share for 2026 (range $0.81 to $1.56); for 2027 the estimate is $1.25.
What is Ardent Health Partners's revenue forecast?
The average revenue estimate for 2026 is $6.5 billion, growth of 2.2%; for 2027 it is $6.7 billion.
When does Ardent Health Partners report earnings?
Ardent Health Partners is expected to report results for the quarter ending September 30, 2026 on November 11, 2026 after the market closes; the EPS estimate is $0.24.
Does Ardent Health Partners usually beat earnings estimates?
Ardent Health Partners reported EPS at or above the analyst estimate in 7 of the last 10 quarters.